✦ LIBER ✦

Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study

✍ Scribed by Kristian Wachtell; Vasilios Papademetriou; Gunnar Smith; Eva Gerdts; Björn Dahlöf; Erik Engblom; Gerard P. Aurigemma; Jonathan N. Bella; Hans Ibsen; Jens Rokkedal; Richard B. Devereux

Book ID: 116189598
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 169 KB
Volume: 148
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2004.03.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relations of diastolic left ventricular

Relations of diastolic left ventricular filling to systolic chamber and myocardial contractility in hypertensive patients with left ventricular hypertrophy (the PRESERVE study)

✍ Vittorio Palmieri; Jonathan N. Bella; Vincent DeQuattro; Mary J. Roman; Rebecca 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Effects of losartan on cardiovascular mo

Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy. A losartan intervention for endpoint reduction (LIFE) study

✍ S.E. Kjeldsen; B. Dahlor; R.B. Devereux 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Change in diastolic left ventricular fil

Change in diastolic left ventricular filling after one year of antihypertensive treatment. The losartan intervention for endpoint reduction in hypertension (LIFE) study

✍ K. Wachtell; J.N. Bella; J. Rokkedal 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 38 KB

812-4 Serum uric acid and ischemic strok

812-4 Serum uric acid and ischemic stroke risk among hypertensive patients with left ventricular hypertrophy: The losartan intervention for endpoint reduction in hypertension (LIFE) study

✍ Jorge R Kizer; Aud Hoieggen; Michael H Alderman; Sverre E Kjeldsen; Bjorn Dahlof 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Cost-effectiveness of losartan-based the

Cost-effectiveness of losartan-based therapy in patients with hypertension and left ventricular hypertrophy: a UK-based economic evaluation of the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study

✍ McInnes, G; Burke, T A; Carides, G 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

The Effects of Losartan Compared to Aten

The Effects of Losartan Compared to Atenolol on Stroke in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy. The LIFE Study

✍ Sverre E. Kjeldsen; Paulette A. Lyle; Jorge R. Kizer; Bjorn Dahlof; Richard B. D 📂 Article 📅 2005 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 153 KB